                         SEQUENCE LISTING

<110>  QUEEN MARY UNIVERSITY OF LONDON
 
<120>  Biosensor device and assembly methods

<130>  N411339WO

<140>  TBC
<141>  2018-11-23

<150>  GB 1719555.3
<151>  2017-11-24

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  79
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sequence for Neuropeptide Y detection

<400>  1
agcagcacag aggtcagatg caaaccacag cctgagtggt tagcgtatgt catttacgga       60

cctatgcgtg ctaccgtga                                                    79


<210>  2
<211>  95
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sequence for cortisol detection

<400>  2
gttgttgttg ggaatggatc cacatccatg gatgggcaat gcggggtgga gaatggttgc       60

cgcacttcgg cttcactgca gacttgacga agctt                                  95


<210>  3
<211>  44
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sequence for DHEAS detection

<400>  3
ctgctctcgg gacgtggatt ttccgcatac gaagttgtcc cgag                        44


<210>  4
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cortisol aptamer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  may be conjugated to azide

<400>  4
ggaatggatc cacatccatg gatgggcaat gcggggtgga gaatggttgc cgcacttcgg       60

cttcactgca gacttgacga agctt                                             85


<210>  5
<211>  80
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Neuropeptide Y aptamer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  may be conjugated to azide

<400>  5
agcagcacag aggtcagatg caaaccacag cctgagtggt tagcgtatgt catttacgga       60

cctatgcgtg ctaccgtgaa                                                   80


<210>  6
<211>  44
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DHEAS aptamer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  may be conjugated to azide

<400>  6
ctgctctcgg gacgtggatt ttccgcatac gaagttgtcc cgag                        44


<210>  7
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sequence of the DNA complementary to cortisol aptamer

<400>  7
aagcttcgtc aagtctgcag tgaagccgaa gtgcggcaac cattctccac cccgcattgc       60

ccatccatgg atgtggatcc attcc                                             85


<210>  8
<211>  85
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Sequence of the non-complementary DNA used in non-complementary 
       control experiment (Figure 19)  and in Example 15

<400>  8
gattcagcaa ttaagctcta agcgatccgc aacactgacc tcttatcaaa aggagcaatt       60

aaaggtactc tctaatcctg acggg                                             85


